Procuring 1375180-30-5: A Guide for Pharmaceutical Buyers
For procurement professionals in the pharmaceutical sector, sourcing high-quality raw materials is a constant challenge that directly impacts product efficacy and cost. 1-[3-(Benzyloxy)propyl]-5-formylindoline-7-carbonitrile, identified by its CAS number 1375180-30-5, is a critical intermediate in the manufacturing of Silodosin, a prominent drug for treating benign prostatic hyperplasia (BPH). This article provides a comprehensive guide for pharmaceutical buyers on how to effectively procure this essential chemical.
Understanding the Role of CAS 1375180-30-5 in Silodosin Production
Silodosin's therapeutic action relies on its precise molecular structure, which is assembled through a multi-step synthesis process. 1-[3-(Benzyloxy)propyl]-5-formylindoline-7-carbonitrile serves as a crucial building block, providing essential structural components for the final Silodosin molecule. Its chemical name, 5-Formyl-2,3-dihydro-1-[3-(phenylmethoxy)propyl]-1H-indole-7-carbonitrile, highlights its complex organic nature. The purity and quality of this intermediate directly influence the final Active Pharmaceutical Ingredient (API) yield and purity. Pharmaceutical buyers must ensure that the intermediate meets stringent specifications, typically appearing as a white powder with an assay of ≥98.0%.
Key Considerations When Buying 1375180-30-5
When looking to buy 1375180-30-5, pharmaceutical buyers should prioritize several factors. Firstly, supplier reliability is paramount. Establishing a relationship with a reputable manufacturer or supplier, especially those based in regions known for chemical production like China, can ensure a consistent supply chain. Secondly, competitive pricing is a major consideration for cost optimization. Buyers are encouraged to request detailed quotes for bulk purchases. Thirdly, product quality cannot be compromised. Insisting on a Certificate of Analysis (CoA) that confirms the intermediate's purity (≥98.0%) and adherence to relevant standards is essential. For R&D purposes, availability in smaller quantities without sacrificing quality is also a key requirement.
Navigating the Supplier Landscape
The global market for chemical intermediates is competitive, with numerous suppliers offering products like 1-[3-(Benzyloxy)propyl]-5-formylindoline-7-carbonitrile. Buyers should conduct thorough due diligence before committing to a supplier. This includes evaluating their manufacturing capabilities, quality control procedures, and customer service responsiveness. Engaging with suppliers for detailed discussions about their products and any necessary documentation (such as DMF support, if applicable) is highly recommended. Many suppliers in China can offer competitive lead times and flexible shipping options, making them attractive partners for international procurement.
Ensuring a Stable Supply Chain for API Production
A stable supply of critical intermediates like 1375180-30-5 is fundamental to the uninterrupted production of Silodosin. Procurement managers should aim to work with suppliers who can demonstrate a robust supply chain and consistent production capacity. Understanding potential lead times for bulk orders and any logistical considerations is crucial for effective planning. By strategically sourcing this intermediate, pharmaceutical companies can maintain production schedules, manage costs, and ultimately deliver essential medications to patients reliably.
In conclusion, procuring 1-[3-(Benzyloxy)propyl]-5-formylindoline-7-carbonitrile (CAS: 1375180-30-5) requires careful attention to supplier reliability, product quality, and competitive pricing. By following these guidelines, pharmaceutical buyers can secure a consistent supply of this vital intermediate, supporting the efficient manufacturing of Silodosin and contributing to better patient outcomes. If you are seeking to purchase this intermediate, make sure to inquire with trusted chemical manufacturers for the best quotes and assured quality.
Perspectives & Insights
Quantum Pioneer 24
“1-[3-(Benzyloxy)propyl]-5-formylindoline-7-carbonitrile, identified by its CAS number 1375180-30-5, is a critical intermediate in the manufacturing of Silodosin, a prominent drug for treating benign prostatic hyperplasia (BPH).”
Bio Explorer X
“This article provides a comprehensive guide for pharmaceutical buyers on how to effectively procure this essential chemical.”
Nano Catalyst AI
“Understanding the Role of CAS 1375180-30-5 in Silodosin Production Silodosin's therapeutic action relies on its precise molecular structure, which is assembled through a multi-step synthesis process.”